DFTX insider buying and SEC filings, explained
Mind Medicine (MindMed) Inc. · CIK 1813814
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$7.0M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 25, 2026 | Planned (10b5-1) | Daniel Karlin (Chief Medical Officer and Director) sold 10,853 shares at about $36.57 ($397K), marked as a 10b5-1 plan trade. Holdings down 1% to 792,846 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 25, 2026 | Planned (10b5-1) | Robert Barrow (CEO and Director) sold 31,550 shares at about $36.57 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 1% to 2,213,090 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 25, 2026 | Planned (10b5-1) | Matthew T. Wiley (Chief Commercial Officer) sold 3,097 shares at about $36.57 ($113K), marked as a 10b5-1 plan trade. Holdings down 1% to 359,036 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 25, 2026 | Planned (10b5-1) | Mark Sullivan (Chief Legal Officer) sold 14,051 shares at about $36.57 ($514K), marked as a 10b5-1 plan trade. Holdings down 3% to 494,228 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 25, 2026 | Planned (10b5-1) | Brandi Roberts (CFO) sold 3,377 shares at about $36.57 ($123K), marked as a 10b5-1 plan trade. Holdings down 1% to 394,528 shares. | SEC filing Filed Sep 29, 2026 |
| Sep 3, 2026 | Planned (10b5-1) | Robert Barrow (CEO and Director) sold 19,023 shares at about $37.94 ($722K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,494,640 shares. | SEC filing Filed Sep 4, 2026 |
| Jun 25, 2026 | Planned (10b5-1) | Mark Sullivan (Chief Legal Officer) sold 13,008 shares at $45.03 ($586K), marked as a 10b5-1 plan trade. Holdings down 4% to 320,571 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 25, 2026 | Planned (10b5-1) | Daniel Karlin (Chief Medical Officer) sold 10,035 shares at $45.03 ($452K), marked as a 10b5-1 plan trade. Holdings down 2% to 503,282 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 25, 2026 | Planned (10b5-1) | Brandi Roberts (CFO) sold 3,013 shares at $45.03 ($136K), marked as a 10b5-1 plan trade. Holdings down 1% to 209,487 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 25, 2026 | Planned (10b5-1) | Robert Barrow (CEO and Director) sold 29,208 shares at $45.03 ($1.3M), marked as a 10b5-1 plan trade. Holdings down 3% to 1,098,246 shares. | SEC filing Filed Jun 26, 2026 |
| Jun 25, 2026 | Planned (10b5-1) | Matthew T. Wiley (Chief Commercial Officer) sold 2,867 shares at $45.03 ($129K), marked as a 10b5-1 plan trade. Holdings down 2% to 174,633 shares. | SEC filing Filed Jun 26, 2026 |
| Mar 25, 2026 | Planned (10b5-1) | Daniel Karlin (Chief Medical Officer) sold 8,018 shares at about $18.47 ($148K), marked as a 10b5-1 plan trade. Holdings down 2% to 413,317 shares. | SEC filing Filed Mar 26, 2026 |
| Mar 25, 2026 | Planned (10b5-1) | Mark Sullivan (Chief Legal Officer) sold 10,702 shares at about $18.47 ($198K), marked as a 10b5-1 plan trade. Holdings down 4% to 271,079 shares. | SEC filing Filed Mar 26, 2026 |
| Mar 25, 2026 | Planned (10b5-1) | Robert Barrow (CEO and Director) sold 24,431 shares at about $18.47 ($451K), marked as a 10b5-1 plan trade. Holdings down 3% to 752,454 shares. | SEC filing Filed Mar 26, 2026 |
| Dec 26, 2025 | Planned (10b5-1) | Daniel Karlin (Chief Medical Officer) sold 5,600 shares at about $13.15 ($74K), marked as a 10b5-1 plan trade. Holdings down 1% to 425,025 shares. | SEC filing Filed Dec 29, 2025 |
| Dec 26, 2025 | Planned (10b5-1) | Robert Barrow (CEO and Director) sold 25,791 shares at about $13.15 ($339K), marked as a 10b5-1 plan trade. Holdings down 3% to 778,477 shares. | SEC filing Filed Dec 29, 2025 |
| Dec 26, 2025 | Planned (10b5-1) | Mark Sullivan (Chief Legal Officer) sold 11,276 shares at about $13.15 ($148K), marked as a 10b5-1 plan trade. Holdings down 4% to 282,576 shares. | SEC filing Filed Dec 29, 2025 |
30 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DFTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.